IMMUNOCYT 1 : A NEW TOOL FOR DETECTING TRANSITIONAL CELL CANCER OF THE URINARY TRACT
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
TNM Classification of Malignant Tumours
1987 • 16,209 citations
Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment
1996 • 330 citations
Diagnostic value of cytology of voided urine.
1985 • 238 citations
Improved detection of recurrent bladder cancer using the bard bta stat test
1997 • 195 citations
CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?
1998 • 177 citations
Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity
1998 • 155 citations
Clinical Evaluation of Nuclear Matrix Protein 22 (NMP22) in Urine as a Novel Marker for Urothelial Cancer
1997 • 128 citations
Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark.
1997 • 121 citations
Clinical Evaluation of Urinary and Serum Carcinoembryonic Antigen in Bladder Cancer
1975 • 53 citations
Critical appraisal of tumor markers in bladder cancer.
1993 • 46 citations
Monoclonal antibody against a tumor‐associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomas
1990 • 34 citations
MAUB Is a New Mucin Antigen Associated with Bladder Cancer
1996 • 19 citations
Monoclonal antibodies in bladder cancer cytology
1991 • 13 citations
Deleted Work
1955 • 0 citations